Sep. 29, 2022—Vanderbilt reseach shows that resources for lung cancer screening programs increased the number of veterans screened.
Sep. 22, 2022—Vanderbilt University Medical Center is partnering with 11 institutions on a $14 million NIH-funded project that aims to establish voice as a biomarker used in clinical care.
Sep. 8, 2022—A Vanderbilt study is testing drugs that provide a targeted fluorescent dye that clings to and illuminates cancer.
Apr. 28, 2022—Combining genetic testing with information from electronic health records revealed undiagnosed heart rhythm disorders and new conditions associated with inherited cancer gene mutations.
Medicare beneficiaries without low-income subsidies were less likely to fill important prescriptions, new study finds
Apr. 4, 2022—Vanderbilt research shows that Medicare Part D beneficiaries who did not receive federal subsidies to lower their out-of-pocket costs were nearly twice as likely as others to not fill prescriptions for serious health conditions like cancer or hepatitis C treatment.
Mar. 24, 2022—Adolescent and young adult oncology patients and caregivers experience psychosocial impairment and financial toxicity at the time of cancer diagnosis, findings that will inform interventions to support patient and caregiver well-being.